Zydus Lifesciences has introduced ANVIMO ... ANVIMO is available in 240 mg and 480 mg dosages and has established bioequivalence with the reference drug. CMV infection is a critical complication ...

Zydus Lifesciences announced it is negotiating to acquire a majority stake in French medtech firm Amplitude Surgical for approximately Rs 2,500 crore. The acquisition aims to boost Zydus's global ...

Until now, innovator Letermovir 240 mg was imported at more than Rs.5 lakh per month, severely limiting access. With the launch of ANVIMO, Zydus has significantly reduced the cost by 91% of the ...

The proposed acquisition shall act as a platform to execute our global MedTech strategy and a natural extension for Zydus having a proven track record in life sciences and wellness segments ...

Zydus Lifesciences on Wednesday (February 26, 2025) said it is introducing a vaccine for protection against new strain of influenza virus. “The company is introducing country’s first flu ...

Zydus Lifesciences Ltd. on Tuesday said it has entered into exclusive negotiations to acquire a majority stake in France-based Amplitude Surgical for €256.8 million. “The acquisition price ...

Zydus Lifesciences Limited on Tuesday announced that the company has entered into exclusive negotiations to acquire majority Amplitude Surgical. Purchase consideration amounts to €256.8mn for 85 ...

Zydus Lifesciences has entered exclusive negotiations to acquire a controlling stake in France-based medtech firm Amplitude Surgical SA for €256.8 million, the drugmaker said on Tuesday, as it ...

Completion of the transaction to be followed by mandatory simplified tender offer Zydus has entered into exclusive negotiations to acquire a controlling shareholding in Amplitude Surgical ...

New Delhi: Indian pharma major Zydus Lifesciences has entered into exclusive negotiations to acquire a majority stake in France-based orthopedic device maker Amplitude Surgical for up to €300 ...

(Reuters) -India's Zydus Lifesciences (ZYDUSLIFE.NS) said on Tuesday it will acquire an 85.6% stake in France's Amplitude Surgical (AMPLI.PA) for 256.8 million euros (nearly $280 million) as part of ...

The company has received tentative approval from the US Food and Drug Administration (USFDA) to market Pimavanserin tablets in strength of 10 mg, Zydus Cadila said in a statement. Zydus Cadila ...